Volume 15, Number 2, March-April 2008

Low-density lipoprotein-apheresis: an update
Stefanos Archontakis, Alison Pottle, Mahmoud Barbir

Low-density lipoprotein (LDL)-apheresis is the treatment of choice in homozygous familial hypercholesterolaemia as well as various other severe dyslipidaemic conditions. However, it appears to be under utilised in the UK. This article reviews the recent advances in (LDL)-apheresis techniques, as well as the beneficial effects and clinical outcomes of this therapeutic modality.

Br J Cardiol 2008;15:83-85.

View full PDF article (open in new window)
Email this article